4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-028689
President sold 110,000 shares at an average $38.10 ($4,190,780)
- President acquired 110,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2020-05-11 | Option exercise | +80,000 | $0.84 | $67,200 | 80,000 | D |
| RUBINSTEIN JULIE President | 2020-05-11 | Sale | −80,000 | $38.00 | $3,040,000 | 0 | D |
| RUBINSTEIN JULIE President | 2020-05-12 | Option exercise | +30,000 | $0.84 | $25,200 | 30,000 | D |
| RUBINSTEIN JULIE President | 2020-05-12 | Sale | −24,860 | $38.20 | $949,652 | 5,140 | D |
| RUBINSTEIN JULIE President | 2020-05-12 | Sale | −5,140 | $39.13 | $201,128 | 0 | D |
| Derivatives | |||||||
| RUBINSTEIN JULIE President | 2020-05-11 | Option exercise · Stock Option (Right to Buy) | −80,000 | 140,000 | D | ||
| RUBINSTEIN JULIE President | 2020-05-12 | Option exercise · Stock Option (Right to Buy) | −30,000 | 110,000 | D | ||
| Open-market sales · 110,000 sh · avg $38.10 · $4,190,780 | |||||||
Loading xslF345X03/doc4.xml…